HER-2 Protein Vaccine in Treating Women With Breast Cancer
This study has been completed.
Sponsor:
University Hospitals Seidman Cancer Center
Collaborator:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00068614
First received: September 10, 2003
Last updated: February 12, 2011
Last verified: October 2003
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |